Skip to content
Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer episode artwork

EPISODE · Apr 23, 2022 · 12 MIN

Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer

from EAU Podcast · host European Association of Urology

Dr. Richard Cathomas, medical oncologist from Zurich in Switzerland discusses Immunotherapy in muscle-invasive bladder cancer. He goes into the mechanism of action of immunotherapy and why could it work well in bladder cancer. Where do we currently stand with the use of immunotherapy in the NEOADJUVANT setting of muscle invasive bladder cancer? And what is currently the best place to integrate immunotherapy for METASTATIC bladder cancer? Prof. Dr. Cathomas closes with the answer to the question of why some patients benefit much more than others from immunotherapy. Prof. Dr. Richard Cathomas is oncologist panel member on the EAU Guidelines for muscle-invasive bladder cancer.

Episode metadata supplied by the publisher feed · Published Apr 23, 2022

Embed this episode

Ready to play

Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer

0:00 12:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of EAU Podcast?

This episode is 12 minutes long.

When was this EAU Podcast episode published?

This episode was published on April 23, 2022.

Can I download this EAU Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!